Is Dentsply Sirona, Inc. overvalued or undervalued?

As of 14 November 2022, the valuation grade for Dentsply Sirona, Inc. moved from expensive to risky, indicating a shift in perception regarding its market value. The company appears to be overvalued based on its current metrics, with a P/E ratio of 22, an EV to EBITDA of 9.86, and a Price to Book Value of 1.94. In comparison, peers such as The Cooper Cos., Inc. have a significantly higher P/E ratio of 34.28, while QIAGEN NV shows a fair valuation with a P/E of 24.20, suggesting that Dentsply Sirona's valuation does not align favorably with its industry counterparts.
The company's stock has underperformed relative to the S&P 500, with a year-to-date return of -29.29% compared to the index's 12.22%. This trend continues over longer periods, with a 5-year return of -71.03% against the S&P 500's 96.61%. Overall, these factors reinforce the conclusion that Dentsply Sirona, Inc. is currently overvalued.